Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Hannelore V Heemers"'
Autor:
Song Liu, Sangeeta Kumari, Qiang Hu, Dhirodatta Senapati, Varadha Balaji Venkadakrishnan, Dan Wang, Adam D DePriest, Simon E Schlanger, Salma Ben-Salem, Malyn May Valenzuela, Belinda Willard, Shaila Mudambi, Wendy M Swetzig, Gokul M Das, Mojgan Shourideh, Shahriah Koochekpour, Sara Moscovita Falzarano, Cristina Magi-Galluzzi, Neelu Yadav, Xiwei Chen, Changshi Lao, Jianmin Wang, Jean-Noel Billaud, Hannelore V Heemers
Publikováno v:
eLife, Vol 6 (2017)
Externí odkaz:
https://doaj.org/article/9aebacceecd24ba98796d96b142dcb42
Autor:
Song Liu, Sangeeta Kumari, Qiang Hu, Dhirodatta Senapati, Varadha Balaji Venkadakrishnan, Dan Wang, Adam D DePriest, Simon E Schlanger, Salma Ben-Salem, Malyn May Valenzuela, Belinda Willard, Shaila Mudambi, Wendy M Swetzig, Gokul M Das, Mojgan Shourideh, Shahriah Koochekpour, Sara Moscovita Falzarano, Cristina Magi-Galluzzi, Neelu Yadav, Xiwei Chen, Changshi Lao, Jianmin Wang, Jean-Noel Billaud, Hannelore V Heemers
Publikováno v:
eLife, Vol 6 (2017)
Standard treatment for metastatic prostate cancer (CaP) prevents ligand-activation of androgen receptor (AR). Despite initial remission, CaP progresses while relying on AR. AR transcriptional output controls CaP behavior and is an alternative therape
Externí odkaz:
https://doaj.org/article/41305a6fc01f416095798be8b5b7c5bf
Autor:
Salma Ben-Salem, Qiang Hu, Yang Liu, Mohammed Alshalalfa, Xin Zhao, Irene Wang, Varadha Balaji Venkadakrishnan, Dhirodatta Senapati, Sangeeta Kumari, Deli Liu, Andrea Sboner, Christopher E. Barbieri, Felix Feng, Jean-Noel Billaud, Elai Davicioni, Song Liu, Hannelore V. Heemers
Publikováno v:
European Urology Open Science, Vol 22, Iss , Pp 34-44 (2020)
Background: Metastatic prostate cancer (CaP) treatments are evolving rapidly but without evidence-based biomarkers to predict responses, and to maximize remissions and survival. Objective: To determine the activity of androgen receptor (AR), the targ
Externí odkaz:
https://doaj.org/article/ba587ec25e6b4c92b3f6ddb1ad16913f
Publikováno v:
Asian Journal of Urology, Vol 7, Iss 3, Pp 219-232 (2020)
Prostate cancer (PCa) progression relies on androgen receptor (AR) action. Preventing AR's ligand-activation is the frontline treatment for metastatic PCa. Androgen deprivation therapy (ADT) that inhibits AR ligand-binding initially induces remission
Externí odkaz:
https://doaj.org/article/4973a60c0f9a4f73afd9b3d8af401f16
Autor:
Ujjwal R. Dahiya, Hannelore V. Heemers
Publikováno v:
Cells, Vol 11, Iss 6, p 936 (2022)
The androgen receptor (AR) is a member of the ligand-activated nuclear receptor family of transcription factors. AR’s transactivation activity is turned on by the binding of androgens, the male sex steroid hormones. AR is critical for the developme
Externí odkaz:
https://doaj.org/article/887c05cfb2b24015a6f6093201db76ce
Supplementary Figure 4 from Androgen Induction of the Androgen Receptor Coactivator Four and a Half LIM Domain Protein-2: Evidence for a Role for Serum Response Factor in Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ab390630a459fd5b51af6aad3c89a38
https://doi.org/10.1158/0008-5472.22370550.v1
https://doi.org/10.1158/0008-5472.22370550.v1
Autor:
Donald J. Tindall, Karla V. Ballman, Song Liu, Dan Wang, Kelly Duncan, S. Keith Anderson, Kevin M. Regan, Zhifu Sun, Lucy J. Schmidt, Hannelore V. Heemers
Supplementary Table 8 from Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0a50f5d7db6b0264ef87fcb7582b6cb
https://doi.org/10.1158/0008-5472.22390944
https://doi.org/10.1158/0008-5472.22390944
Supplementary Figure 3 from Androgen Induction of the Androgen Receptor Coactivator Four and a Half LIM Domain Protein-2: Evidence for a Role for Serum Response Factor in Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::356aa9a98421062ba7e20eb9ec211a55
https://doi.org/10.1158/0008-5472.22370553.v1
https://doi.org/10.1158/0008-5472.22370553.v1
Supplementary Figure 1 from Androgen Induction of the Androgen Receptor Coactivator Four and a Half LIM Domain Protein-2: Evidence for a Role for Serum Response Factor in Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a27071d86f33e0843d5ce6c6278a928
https://doi.org/10.1158/0008-5472.22370559.v1
https://doi.org/10.1158/0008-5472.22370559.v1
Supplementary Figure 5 from Androgen Induction of the Androgen Receptor Coactivator Four and a Half LIM Domain Protein-2: Evidence for a Role for Serum Response Factor in Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e5a63560248faf147d57827b79b0a34
https://doi.org/10.1158/0008-5472.22370547
https://doi.org/10.1158/0008-5472.22370547